Latest articles in

Webinar
21 Oct, 2025
Multimodal Imaging of Cellular Senescence: Tissue Cytometry and Beyond
Dr. Florian Gruber and Christopher Kremslehner, MUV, summarize what is known about the cell senescence in skin and present new research done in the SKINMAGINE lab, focusing on aging in tissues using multimodal imaging.

App
30 Jul, 2025
New StrataQuest App: IF ARTIFICIAL SKIN
The IF Artificial Skin App stratifies skin equivalents into dermis and epidermis, further dividing the epidermis into stratum corneum, suprabasal, and basal layers. It outputs area, mean staining intensity, nuclei counts, and % of marker-positive cells for each layer and sublayer. Read publication here

Blog Post
20 Jan, 2025
What is AI-Powered Tissue Classification?
AI-powered tissue classification applies machine learning to identify and categorize tissue types. It supports consistent, quantitative analysis of morphology, tumor microenvironments, and disease processes in research and diagnostics.

Blog Post
06 May, 2024
Imaging in Histopathology: Pyknotic Nuclei
Pyknotic nuclei, key indicators of cell death, are critical in histopathology and disease research. Using advanced imaging and TissueGnostics’ IF Pyknotic Nuclei App, researchers can achieve automated, accurate detection and quantification for deeper diagnostic insights.

Blog Post
25 Mar, 2024
Understanding the Role of Artificial Intelligence in Imaging Cytometry
AI is transforming imaging cytometry by enabling automated, accurate nuclei segmentation and tissue detection. With solutions like StrataQuest, researchers gain higher precision, efficiency, and insights into cellular structures for biomedical research and diagnostics

Blog Post
17 May, 2023
An Intro to Deep Learning in Biomedical Imaging
Deep learning has become a powerful tool in biomedical imaging, enabling accurate cell segmentation, phenotype detection, and analysis of complex tissue structures. TissueGnostics offers AI-driven nuclei segmentation to improve efficiency and precision in image analysis.

Customer Publication
11 Nov, 2022
COL8A1 Promotes Tumor in Pancreatic Ductal Adenocarcinoma
Yan et al. identified COL8A1 as a potential biomarker of poor chemotherapy response and survival in PDAC. TissueFAXS and StrataQuest enabled imaging and segmentation of tumor structures.
